| 7.17 |  -0.42 / -5.53% |
Data as of 4:00pm ET | Day’s Change |
| 7.17 |  0.00 / 0.00% |
Volume: 8.0K |
| Previous close | 7.59 |
| Today’s open | 7.59 |
| Day’s range | 7.03 - 7.74 |
| Volume | 1,247,909 |
| Average volume (3 months) | 1,352,503 |
| Market cap | $858.9M |
| Dividend yield | -- |
| Earnings growth (last year) | -152.63% |
| Earnings growth (this year) | -19.16% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -24.54% |
| P/E ratio | NM |
| Price/Sales | 17.61 |
| Price/Book | 17.51 |
| Today’s change | Today’s % change | |
|---|---|---|
| ITMNInterMune Inc | -0.40 | -4.00% |
| SZYMSolazyme Inc | -0.72 | -6.24% |
| MNTAMomenta Pharmaceutic... | +0.18 | +1.38% |
| GEVASynageva Biopharma C... | +0.77 | +1.95% |
| Next reporting date | August 9, 2013 |
| EPS forecast (this quarter) | -$0.14 |
| Annual revenue (last year) | $42.3M |
| Annual profit (last year) | -$53.6M |
| Net profit margin | -126.53% |
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Gregory Ian Frost, PhD |
Vice President-Manufacturing & Operations William J. Fallon, PhD |
Corporate headquarters San Diego, California |
.
